Drug recall · August 29, 2018
Valsartan Tablets USP recall
Why: Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Valsartan Tablets USP, 40 mg, 30-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd Roorkee 0247661 India, Marketed by: Jubilant Cardista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-360-30
- Lots / codes
Lot #: VR117014A, VR117015A, Exp. 08/2019
- Quantity
- 10,577 bottles
- Company
- Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD
- Distribution
- Product was distributed throughout the United States to wholesalers and retailers.
- Initiated
- August 14, 2018 · Voluntary: Firm initiated
- Classified
- August 17, 2018
- Reported
- August 29, 2018
- Ended
- January 8, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Valsartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.